Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Madrigal Pharmaceuticals (MDGL) over the last 11 years, with Sep 2025 value amounting to -$9.3 million.

  • Madrigal Pharmaceuticals' Other Working Capital Changes fell 257.26% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 60.45%. This contributed to the annual value of $10.6 million for FY2024, which is 1816.40% up from last year.
  • As of Q3 2025, Madrigal Pharmaceuticals' Other Working Capital Changes stood at -$9.3 million, which was down 126.23% from $35.4 million recorded in Q2 2025.
  • Madrigal Pharmaceuticals' Other Working Capital Changes' 5-year high stood at $35.4 million during Q2 2025, with a 5-year trough of -$9.3 million in Q3 2025.
  • Over the past 3 years, Madrigal Pharmaceuticals' median Other Working Capital Changes value was $928,000 (recorded in 2024), while the average stood at $4.2 million.
  • Examining YoY changes over the last 5 years, Madrigal Pharmaceuticals' Other Working Capital Changes showed a top increase of 10,096.61% in 2024 and a maximum decrease of 22,209.38% in 2024.
  • Quarterly analysis of 5 years shows Madrigal Pharmaceuticals' Other Working Capital Changes stood at -$2.5 million in 2021, then spiked by 46.44% to -$1.3 million in 2022, then soared by 102.42% to $32,000 in 2023, then plummeted by 22,209.38% to -$7.1 million in 2024, then slumped by 257.26% to -$9.3 million in 2025.
  • Its last three reported values are -$9.3 million in Q3 2025, $35.4 million for Q2 2025, and $9.5 million during Q1 2025.